Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutaredoxin is a small redox enzyme and member of the thioredoxin protein family, present in nearly all organisms from bacteria to humans[1][2][3][4]. It contains a catalytic site typically composed of a cysteine pair (Cys-X-X-Cys motif), enabling it to catalyze the reversible reduction of protein or substrate disulfides using glutathione as a cofactor. Uniquely, glutaredoxins use the glutathione system—specifically, reduced glutathione (GSH) as an electron donor and glutathione reductase for GSH recycling—instead of a dedicated reductase protein[1][3][5]. Their primary roles include maintenance of cellular redox homeostasis, defense against oxidative stress, and regulation of protein function via reversible protein S-glutathionylation and deglutathionylation, crucial in a wide range of physiological and pathological contexts, from DNA synthesis (as hydrogen donor for ribonucleotide reductase) to the assembly and transfer of iron-sulfur clusters important for mitochondrial function[2][3][4]. Glutaredoxins have distinct isoforms (e.g. GLRX1, GLRX2, GLRX3, GLRX5) with specialized functions and localizations in cells[3][7]. Dysregulation or mutation in glutaredoxins has been implicated in cancer, neurodegeneration, cardiovascular conditions, and immune disorders, supporting ongoing interest in the class as putative therapeutic targets and biomarkers[2][3][4].
Catalysis of glutathione-dependent reduction of disulfides and mixed disulfides, regulating cellular redox state and modulating protein function via reversible glutathionylation[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutaredoxin (Grx).